https://www.selleckchem.com/pr....oducts/sch-527123.ht
The total score of clinical signs significantly decreased after 2weeks and remained effective thereafter. Tacrolimus eye drops elicited a statistically significant difference in the mean total clinical scores and IOP over the course of treatment (P 0.001). Elevated IOP was observed in 2 cases and corneal infection in 1 case; these effects were completely controlled with medication. Topical tacrolimus may provide effective and long-term improvement in clinical signs of severe AKC and VKC cases that refractory to standard conventi
Curtir
Comentario
Compartilhar
